Oxford Biomedica Plc
Oxford BioMedica is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines.
The company has a platform of gene delivery technologies, which are predominately based on highly engineered viral systems.
Oxford BioMedica was established in 1995 as a spin-out from the University of Oxford. The company listed on AIM in 1996 and moved to the official list of the London Stock Exchange in 2001 (LSE:OXB).